Track Vivo Bio Tech Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -4.18 %
Low
22.9
High
24.4
1 Month returns: -5.48 %
Low
22.2
High
25.2
1 Year returns: -36.90 %
Low
20.4
High
43.4
3 Year CAGR: -5.57 %
Low
20.4
High
56.9
5 Year CAGR: -23.12 %
Low
18.1
High
104.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Vivo Bio Tech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Vivo Bio Tech Ltd. Shareholding Pattern
Quarterly breakdown of Vivo Bio Tech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Vivo Bio Tech Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Vivo Bio Tech Ltd.?
The current share price of Vivo Bio Tech Ltd. is ₹ 22.95 as of 8 Jul 2026.
What is the market capitalisation of Vivo Bio Tech Ltd.?
The market capitalisation of Vivo Bio Tech Ltd. stands at ₹ 50.93 Cr.
What is the PE ratio of Vivo Bio Tech Ltd.?
The Price-to-Earnings (PE) ratio of Vivo Bio Tech Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Vivo Bio Tech Ltd.?
Vivo Bio Tech Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of Vivo Bio Tech Ltd.?
The 52-week high of Vivo Bio Tech Ltd. is - and the 52-week low is -.
What is the dividend yield of Vivo Bio Tech Ltd.?
The dividend yield of Vivo Bio Tech Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Vivo Bio Tech Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 40.20% of Vivo Bio Tech Ltd. shares.
What sector does Vivo Bio Tech Ltd. belong to?
Vivo Bio Tech Ltd. operates in the Healthcare sector.
What is the beta of Vivo Bio Tech Ltd.?
The beta of Vivo Bio Tech Ltd. is 0.99, indicating its price volatility relative to the broader market. Over the past 1 year, Vivo Bio Tech Ltd. has delivered an absolute return of -37.97%.
What is the RSI of Vivo Bio Tech Ltd.?
The 14-day Relative Strength Index (RSI) of Vivo Bio Tech Ltd. is 38.66, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Vivo Bio Tech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Consistently pays dividend
The company has not missed dividend payments once in the last 10 financial years
What is Dividend streak?
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Earnings yield of -16.16% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis
What is Earnings yield (E/P)?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -177.85% for 12-month ended 31 Mar 2026 and the growth was 146.54 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 14.27% for 12-month ended 31 Mar 2026 and the growth was 0.0 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 14.27
Value 14.27
-78.3517.09
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.044258.
Company Profile
Overview of Vivo Bio Tech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Companys services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services.
Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agroch...
Key personnel
Bhavish Vijayvargiya
Compliance Officer, Company Secretary
Mr. Kompella Sri KalyanD
Chief Financial Officer, Additional Whole-time Director
Mangipudi Kalyan RamD
Whole Time Director
Mr. Tejomurthula Viswaswara Kaladhar KuppambhotlaD